MedPath

VB-201

Generic Name
VB-201
Drug Type
Small Molecule
Chemical Formula
C29H60NO8P
CAS Number
630112-41-3
Unique Ingredient Identifier
SJ5A8151JO

Overview

VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).

Background

VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial
Phase 1
Withdrawn
Posted: 2021/06/25
Sponsor:
Priscilla Hsue, MD
ID:NCT04939311
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Phase 2
Completed
Posted: 2021/02/02
Sponsor:
Vascular Biogenics L...
ID:NCT04733833
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
Phase 2
Completed
Posted: 2013/04/24
Sponsor:
Vascular Biogenics L...
ID:NCT01839214
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis
Phase 2
Completed
Posted: 2013/04/23
Sponsor:
Vascular Biogenics L...
ID:NCT01837420
Study to Assess the Safety and Efficacy of Multiple Doses of VB-201 on Biomarkers
Phase 2
Completed
Posted: 2010/07/09
Sponsor:
Vascular Biogenics L...
ID:NCT01159730

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy